A double-blind comparative study of ampicillin, co-trimoxazole and josamycin in anthraco-silicotic miners, assessed by transtracheal puncture.
D000667:Ampicillin / Q000627:therapeutic use*; D000874:Anthracosilicosis / Q000150:complications*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D001991:Bronchitis / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology; D002986:Clinical Trials as Topic; D003032:Coal Mining; D003354:Corynebacterium Infections / Q000188:drug therapy; D004311:Double-Blind Method; D004338:Drug Combinations; D006192:Haemophilus Infections / Q000188:drug therapy; D006193:Haemophilus influenzae; D006801:Humans; D007933:Leucomycins / Q000627:therapeutic use*; D009343:Neisseria; D011008:Pneumococcal Infections / Q000188:drug therapy; D011552:Pseudomonas Infections / Q000188:drug therapy; D011677:Punctures; D013420:Sulfamethoxazole / Q000008:administration & dosage / Q000627:therapeutic use*; D014132:Trachea / Q000382:microbiology; D014295:Trimethoprim / Q000008:administration & dosage / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D007933:Leucomycins; D000667:Ampicillin; D014295:Trimethoprim; D013420:Sulfamethoxazole